Eating protein at regular intervals helps retrigger MPS throughout the day
Lose 14-15% of your body weight* *In clinical trials of Wegovy (FDA-approved semaglutide), participants achieved an average weight loss of approximately 15% over 68 weeks, with some participants achieving up to 20% with continued treatment and adherence, when combined with diet and exercise
Symptoms That Warrant Contacting Your Provider Promptly Severe or persistent abdominal pain, repeated vomiting preventing fluid intake, signs of dehydration such as fainting, confusion, or very low urination particularly if you take diuretics or have kidney disease and any new or worsening mood changes
The success of clinical trials with exenatide and liraglutide sparked growing interest in therapies based on GLP-1
Adding more BAC water does not fix this the issue is pH, not volume